The NGDO Co-ordination Group for Onchocerciasis Control
The NGDO Co-ordination Group for Onchocerciasis Control
复制标题
DOI：
10.1179/136485908x337472
复制
发表时间：
2008-09-01
影响因子：
--
通讯作者：
Haddad, D.
中科院分区：
文献类型：
--
作者：
Haddad, D.
自从默克公司开始捐赠Mectizan以来，股份有限公司、非政府发展组织积极参与大规模分发这种药物以控制盘尾丝虫病。2006年，参与盘尾丝虫病控制的非政府组织发展组织网络协助治疗了6 200多万人。目前在非洲采用的分发战略，即社区指导的伊维菌素治疗，非常适合与其他保健活动相结合。NGDO一直是综合全面眼科护理、疟疾驱虫蚊帐、控制多种“被忽视的”热带疾病和补充维生素A的先驱。这些扩大的活动带来了新的挑战，需要所有合作伙伴加以应对，非政府发展组织将在这方面发挥积极作用。
Since the beginning of the donation of Mectizan by Merck & Co., Inc., non-governmental development organizations (NGDO) have been actively involved in the mass distribution of this drug to control onchocerciasis. In 2006, the network of NGDO involved in onchocerciasis control assisted in the treatment of over 62 million people. The current strategy that is used for distribution in Africa, community-directed treatment with ivermectin (CDTI), is very well suited for integration with other health activities. NGDO have been the pioneers in integrating comprehensive eye care, insecticide-treated nets for malaria, the control of multiple 'neglected' tropical diseases, and vitamin-A supplementation. These expanded activities bring with them new challenges, which need to be addressed by all partners and where the NGDO will play an active role.